15,549 results on '"RENAL cancer"'
Search Results
2. Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
3. Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
4. Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) (SABINA)
5. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
6. Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery (SMILe)
7. Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
8. The Man Van Project (MV)
9. Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (OligoRARE)
10. Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
11. A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
12. A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
13. Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
14. The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) (#HOPE4KIDNEY)
15. Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
16. The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy (CAIN)
17. Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
18. Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry (SMART)
19. 9-ING-41 in Patients With Advanced Cancers
20. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)
21. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
22. Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus (NEOPAX)
23. Renal Cancer Detection With Liquid Biopsy (GaGnostic)
24. 68Ga-PSMA PET in the Renal Cell Carcinoma
25. A Study of HB0025 Injection in Patients With Advanced Renal Cancer
26. National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) (PRO-RCC)
27. Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
28. The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
29. Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance.
30. Epigenetic dysregulated long non-coding RNAs in renal cell carcinoma based on multi-omics data and their influence on target drugs sensibility.
31. Retroperitoneal schwannoma mimicking a metastatic lymph node of renal clear cell carcinoma: a case report.
32. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles.
33. Multidisciplinary cancer disease classification using adaptive FL in healthcare industry 5.0.
34. New insight into the CNC-bZIP member, NFE2L3, in human diseases.
35. Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis.
36. Renal cell carcinoma.
37. MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications.
38. Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma.
39. 3D virtual model for robot-assisted partial nephrectomy in highly-complex cases (PADUA ⩾ 10).
40. MMP-14 Exhibits Greater Expression, Content and Activity Compared to MMP-15 in Human Renal Carcinoma.
41. Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer.
42. Extracorporeal Removal of Per- and Polyfluoroalkyl Substances by Hemoadsorption: In vitro Kinetic Model.
43. Visual extended reality tools in image-guided surgery in urology: a systematic review.
44. Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
45. Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan.
46. Fumarate hydratase–deficient renal cell carcinoma: an oncology care institutional experience.
47. Renal cancer: signaling pathways and advances in targeted therapies.
48. Dose–response relationship between arsenic in drinking water and mortality of urinary cancers in Taiwan.
49. Renal cell carcinoma in a transplanted kidney: a retrospective evaluation.
50. Increased risk of cardiovascular disease among kidney cancer survivors: a nationwide population-based cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.